FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and relates to a method for producing an inclusion complex disulfiram (DSF) with unsubstituted or substituted cyclodextrin, for which unsubstituted cyclodextrin (NDC) or a substituted cyclodextrin selected from group consisting of methylcyclodextrin (MCS), dimethylcyclodextrin (DMCD), trimethylcyclodextrin (TMCD) and hydroxypropylcyclodextrin (HPCD), taken in solid form or dissolved in water or alcohol while stirring and a temperature of 20 to 70 °C combined with disulfiram (DSF) as a solid, melt or alcoholic solution, wherein alcohol is selected from methanol, ethanol, n-propanol or iso-propanol, molar ratio of HPβCD and DSF is from 2.01:1 to 2.40:1, mixture is cooled to 0-25 °C, lyophilised and subjected to filtration or solvent is evaporated.
EFFECT: technical result is a method for producing a water soluble inclusion complex of cyclodextrin with disulfiram - active ingredient of eye drops, which can be isolated in a purity satisfying requirements of State Pharmacopoeia of Russia.
7 cl, 5 ex, 6 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
INCLUSION COMPLEX OF DISULFIRAM AND CYCLODEXTRIN | 2015 |
|
RU2592625C1 |
DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
PHARMACEUTICAL COMPOSITIONS OF PYRIMIDINE-2, 4, 6-TRIONES | 2005 |
|
RU2411043C2 |
AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY | 2013 |
|
RU2662314C2 |
APPLICATION OF TRIOXOPYRIMIDINE FOR TREATMENT AND PREVENTION OF INFLAMMATORY BRONCHIAL DISEASES | 2005 |
|
RU2402329C2 |
METHOD OF PRODUCING BRANCHED OLIGOHEXAMETHYLENE GUANIDINE SALTS HAVING DEGREE OF PURITY SUFFICIENT FOR USE THEREOF AS PHARMACEUTICAL SUBSTANCE | 2019 |
|
RU2729421C1 |
DISULPHIRAM IMPLANT FOR TREATING ALCOHOL OR OPIATE ADDICTIVE PATIENTS | 2012 |
|
RU2495679C1 |
POLYMERIC MATERIAL OF MEDICAL PURPOSE FOR EMBOLIZATION | 2017 |
|
RU2669801C1 |
IMPLANTABLE MEDICATION DISULFIRAM-BASED FOR TREATMENT OF ALCOHOL OR OPIATE-DEPENDENT PATIENT | 2012 |
|
RU2475272C1 |
COMPOSITIONS BASED ON CYCLODEXTRIN AND A BUDESONIDE DERIVATIVE AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2722414C2 |
Authors
Dates
2016-04-10—Published
2015-02-03—Filed